Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

BlackArch Partners Announces Hiring of Doug Bolt as Managing Director and Head of Healthcare Industry Practice


News Image

BlackArch Partners, a leading middle-market investment bank, is pleased to announce that Doug Bolt has joined the firm as Managing Director. He will serve as head of BlackArch’s Healthcare industry group.

Mr. Bolt has more than 20 years of experience in the banking industry including nearly fifteen years advising on mergers and acquisitions in the middle market with particular focus in the healthcare and life science sectors. His sector-specific experience includes Healthcare Information Technology, Home Health, Medical Devices, Payor Services, Pharmacy, and Physician Practice Management. He has advised on sell-side, buy-side, and equity and debt capital raising during his investment banking career.

Prior to joining BlackArch, Mr. Bolt was head of the Life Sciences and Healthcare practice for Deloitte Corporate Finance, the investment banking group of Deloitte. Previously in his career, Mr. Bolt worked at McColl Partners, Edgeview Partners, and Bank of America. While at Edgeview, he was colleagues with many of BlackArch’s senior bankers.

Mr. Bolt earned a bachelor of arts degree from Wake Forest University. He holds a master’s degree in business administration from the Fuqua School of Business at Duke University.

Mr. Bolt lives in Charlotte with his wife, daughter, and two sons.

About BlackArch Partners

BlackArch Partners is a leading middle-market investment bank offering services to financial sponsors, private companies, and diversified corporations. BlackArch addresses the needs of entrepreneurs, founders, and shareholders of private companies with specialized services that include M&A advisory, strategic advisory, and private capital solutions. Headquartered in Charlotte, N.C., BlackArch features a total of 12 industry-focused practices that cover all sectors of interest to middle-market investors; BlackArch professionals have closed over 350 transactions in 16 countries on four continents.

Please visit our website, http://www.blackarchpartners.com, for more details.

Securities offered through BlackArch Securities LLC. Member FINRA and SIPC. Testimonials may not be representative of the experience of all clients. Testimonials are not a guarantee of future performance or success.

Share article on social media or email:

Kyowa Hakko Explores Evolving Consumer Viewpoints on Cognitive, Immune Health


Immune and cognitive health represent two of the brightest opportunities for product development.

Part of being a market leader in our categories mean that we must keep our finger on the pulse of what’s motivating consumers to buy

Immune and cognitive health represent two of the brightest opportunities for product development in the supplement space, new consumer surveys from Kyowa Hakko indicate.

The company recently launched two new white papers, Exploring the Evolving Consumer Attitudes About Immunity Support and New Survey Reveals What’s Driving Consumers to Energy Drinks and Supplements, both of which share the results of two proprietary consumer surveys.

The first paper focuses on immune health, a category that has flourished as post-pandemic life returns to normal for consumers. Two-in-five (40%) of U.S. consumers surveyed (n=503) report taking supplements to support immunity in the last 12 months, and of those, more than three-in-four do so as part of their regimen for long-term immune support.

“This renewed focus on immune health indicates that consumers are looking for new solutions to ensure they’re feeling and performing their best every day,” said Karen Todd, MBA, RD, Vice President of Global Brand Marketing, Kyowa Hakko USA, Inc. “That’s where ingredients like our IMMUSE™ postbiotic come into play, those that present a new mechanism of action for immune health and are backed by numerous clinical studies.”

IMMUSE™ works by activating immune cells called pDCs (plasmacytoid dendritic cells), which are unique cells that promote optimal function of the immune system*.

Aligned with the increasing conversation around immune health is the focus on cognitive health. Kyowa’s survey indicated that among U.S. supplement consumers (n=501), four-in-five said it is important to their quality of life to have mental focus, mental energy, and the ability to concentrate.

“So many of us experience a number of different stressors throughout our day that are jeopardizing our ability to focus, think clearly, and keep our mental energy up,” Todd said. “Consumers want more products that include ingredients that are clinically researched to help us overcome those challenges and improve brain health, like Cognizin® citicoline.”

Cognizin® is a nootropic that has been clinically researched to support brain energy, focus, attention, and memory*. It is available in more than 200 products around the globe, including Lemme Focus gummies and CENTR Enhanced sparkling water.

In both the cognitive and immune health market, functional beverages are emerging as major opportunities for brands. Nearly one-third of supplement consumers said they feel undeserved and unsatisfied with the current market for both immune- and cognitive-boosting drinks.

“Our surveys are telling us that beverages are a major white space for product development, as consumers look for more opportunities to get functional ingredients into their bodies through their diets,” Todd said.

Kyowa also conducted a study with Ipsos (n=3,016) that indicated that consumers highly value branded or trademarked ingredients like Cognizin® and IMMUSE™, and that they are closely linked with trust and clinical studies. The survey also showed that Cognizin®’s and IMMUSE™’s awareness among brain or immune supplement users are higher than competitors.

Ongoing trend reporting and market insight is part of the key value that Kyowa Hakko brings to its customers.

“Part of being a market leader in our categories mean that we must keep our finger on the pulse of what’s motivating consumers to buy,” Todd said.

More information on both ingredients, including where to buy products that contain them, can be found on the Cognizin® and IMMUSE™ websites.

*The Food and Drug Administration has not evaluated these statements. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, EYEMUSE™ Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.

Share article on social media or email:

Aeroflow Healthcare Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance


“We are proud to provide our customers with the assurance that their sensitive data and information are protected with the utmost care and diligence,” said Casey Hite, CEO at Aeroflow Healthcare.

Aeroflow Healthcare, a leading provider of Durable Medical Equipment, today announced that its technology platform used to store, process, maintain, and transmit customer electronic protected health information (ePHI) has earned has earned certified status by HITRUST for information security.

HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the organization’s national offices have met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places Aeroflow Healthcare in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

“This achievement is a testament to our unwavering commitment to ensuring the highest standards of security and compliance in the healthcare industry,” said Casey Hite, CEO at Aeroflow Healthcare. “We are proud to provide our customers with the assurance that their sensitive data and information are protected with the utmost care and diligence. This certification reinforces our position as a trusted partner in the healthcare community and sets us apart as a leader in the industry.”

“HITRUST Certification is globally recognized as validation that information security and privacy controls are effective and compliant with various regulations. HITRUST Certification is considered the gold standard because of the comprehensiveness and applicability of the control requirements, depth of the assurance process, and level of oversight that ensures accuracy,” said Jeremy Huval, Chief Innovation Officer, HITRUST. “Individually, each element exceeds most other programs, and collectively they make HITRUST Certification the most comprehensive, transparent, consistent, and highest quality assessment available.”

About Aeroflow Healthcare

Aeroflow Healthcare navigates the complicated world of insurance coverage, connecting patients with available medical devices and ongoing support. With a large catalog of products, paired with education, and personalized services, the health-solutions provider has guided millions of wellness journeys since 2001 and is one of the fastest-growing private companies in the nation. To learn more about Aeroflow Healthcare and getting medical equipment through insurance, visit http://www.aeroflowinc.com.

Share article on social media or email:

Curio Wellness Names Stephanie Boughner as Chief People & Culture Officer


News Image

“Stephanie’s experience with multi-state operations, an hourly workforce, and leadership development will help us capitalize on our current skills while building out our team with new expertise.” – Michael Bronfein, CEO of Curio Wellness

Curio Wellness, Maryland’s leading cannabis company serving patients with targeted and effective cannabis-based therapeutics developed through state-of-the-art technology and cutting-edge plant science, today announced that it has recruited Stephanie Boughner as the company’s Chief People & Culture Officer.

In her role, Boughner will be responsible for developing and executing a robust strategic talent planning process focused on consistent performance, internal talent development and succession planning for key roles in order to ensure lines of business are consistently executing the most innovative people strategies.

Boughner joins Curio with over a decade of experience in Human Resources at Aramark Corporation. Most recently, she served as their VP of Human Resources for Sports and Entertainment where she was responsible for developing, implementing, directing and evaluating all human resource functions and talent activities. She led a team of 70 human resource professionals and partners across the Aramark Sports and Entertainment line of business, responsible for approximately $1.6b in revenue and over 25,000 employees across the United States and Canada.

“At Curio Wellness, we believe that a successful business can only be achieved through a successful team. Stephanie’s range of experience with multi-state operations, an hourly workforce, and leadership development will help us capitalize on our current skills while building out our team with new expertise,” said Michael Bronfein, CEO of Curio Wellness. “Her leadership skills in executive coaching and change management efforts will ensure that we continue to foster a team dedicated to solidifying Curio’s position as a market leader. I look forward to collaborating with Stephanie on new and innovative strategies to help shape the future of our organization.”

###

About Curio Wellness

Founded in 2014 in Baltimore, Maryland, Curio Wellness is a cGMP certified, vertically integrated cannabis company and trusted healthcare partner. Recognized as the leading wellness brand in cannabis by BDS Analytics, Curio is committed to serving patients with targeted, effective, and reliable cannabis-based medicine. For more information visit https://curiowellness.com.

Share article on social media or email:

National Infertility Awareness Week® brings awareness activities across the country


News Image

From coast to coast, people who struggle to build a family and those that support them will discover ways to “find their voice”. Whether it’s through social media or in a meeting with their lawmaker, they will find the strength to share their story and make an impact.

RESOLVE: The National Infertility Association (RESOLVE) will recognize National Infertility Awareness Week®, April 23 through April 29, 2023. The movement brings together millions of Americans who want to remove the stigmas and barriers that stand in the way of building families. RESOLVE will rally the infertility community to raise awareness about the significant lack of access to family building options and emotional support for millions of women and men struggling to build a family. #FindYourVoice will be a message found on the official NIAW website and throughout RESOLVE’s social media campaigns.

“From coast to coast, people who struggle to build a family and those that support them will discover ways to “find their voice”. Whether it’s through social media or in a meeting with their lawmaker, they will find the strength to share their story and make an impact,” said Barbara Collura, RESOLVE’s President/CEO. “Let’s use NIAW to raise our voices, talk about the issues too many of us face, and ensure we continue supporting those most in need.”

A few highlights of the week include:

  • Advocacy Day, Tuesday, April 25th: More than 500 advocates from around the country will talk with Members of Congress at RESOLVE’s Virtual Advocacy Day in partnership with the American Society for Reproductive Medicine. Advocates will talk about pro-family policies including equal access to reproductive medical care, insurance coverage for IVF and fertility preservation, and dismantling barriers to adoption.
  • Empire State Building Ceremony, Tuesday, April 25th: RESOLVE and NIAW Sponsor Progyny and fertility advocate, NAACP and Daytime Emmy® award-winning television host, acclaimed pop-vocalist, and founder of the Faith & Familia Foundation, Adrienne Bailon-Houghton will light the Empire State Building orange, the official awareness color.
  • Instagram Lives, Monday April 24th and Thursday April 27th: RESOLVE and NIAW Sponsor First Response® will bring together experts to talk about mental health and how to transition from your Ob/Gyn to a Fertility Specialist.
  • RESOLVE’s 5-Day Challenge: Social media activities that help the community lead the conversation about challenges they face when trying to build a family. Buildings and monuments across the U.S. will shine bright in orange including San Francisco, CA; Charlotte, NC; Boston, MA; New York, NY; Trenton, NJ and more. Providers and community advocates are hosting events and fundraisers both virtually and in-person.

RESOLVE’s National Infertility Awareness Week 2023 is supported by the following partners: Church & Dwight Co., Inc. makers of First Response™; CooperSurgical; EMD Serono; Encompass Fertility by CVS; Ferring Pharmaceuticals; Organon; Progyny; TMRW Life Sciences; and US Fertility.

NIAW, founded by RESOLVE in 1989, became a federally recognized health observance by the Department of Health and Human Services in 2010. RESOLVE can provide experts for interviews on all aspects of infertility, and personal patient stories from women and men struggling to build their families. Find out more about NIAW at infertilityawareness.org.

About RESOLVE: The National Infertility Association: Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure equal access to all family building options for men and women experiencing infertility or other family building challenges. One in six people globally have infertility RESOLVE addresses this public health issue by providing community to these women and men, connecting them with others who can help, empowering them to find resolution and giving voice to their demands for access to all family building options. For more information, visit http://www.RESOLVE.org.

Share article on social media or email:

AvevoRx WELCOMES JENNIFER GEORGE AS DIRECTOR, ACUTE REVENUE CYCLE MANAGEMENT


“My mission is to build an industry-best intake and reimbursement team that helps position AvevoRx as a true market leader that has established trust with its patients.”

AvevoRx, a national, independent provider of specialty infusion pharmacy services, announced today that Jennifer George joins the company as Director of Acute Revenue Cycle Management. Jennifer’s hire marks an important growth milestone for AvevoRX, which has been rapidly expanding its capabilities and national footprint to reach more customers in need of specialized pharmaceutical solutions.

As Director, Jennifer will oversee critical coordination and standardization of acute revenue cycle processes and procedures for AvevoRx. This will help further scale the company’s fast-paced growth toward the top of preferred pharmaceutical provider lists.

“We are looking forward to explosive growth over the next several months and years, and we must build a revenue cycle infrastructure and knowledge base that scales the acute business and minimizes growing pains,” said Robin Johnson, Chief Financial Officer for AvevoRx. “Jennifer sees beyond the day-to-day needs of her role. Like our entire team, she understands that stability within our revenue cycle is a tenant of our patient-centric delivery model. We’re very excited to see the impact of her work as we continue to grow.”

“It’s my goal to ensure we build what’s needed to provide the best possible financial service to our patients, case managers, and team members,” said Jennifer. “My mission is to build an industry-best intake and reimbursement team that helps position AvevoRx as a true market leader that has established trust with its patients. They deserve peace of mind that no surprise bills are coming their way, and to know they have experts working tirelessly on their behalf.”

A native of Shelbyville, TN, Jennifer comes to AvevoRx from a Dallas-based pharmaceutical company, where she served as reimbursement cycle manager since 2014. Before that, she held supervisory roles in home health and specialty pharmacy companies and operational management.

Jennifer holds a Bachelor’s in business administration from Middle Tennessee State University, where she majored in accounting. She lives with her family in Fayetteville, T

Visit AvevoRx.com for more information.

About AvevoRx

AvevoRx is a bespoke, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients facing various complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies for patients with short-term therapeutic needs on a regional basis. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit http://www.AvevoRx.com or follow us on Instagram or LinkedIn.

Share article on social media or email:



Windsor Public Schools Transform Culture, Build Coherence Through High-Quality SEL Program


I am immensely proud of the work being done by our teachers, SEL Specialists and support staff who are committed to nurturing the social-emotional well-being of our students.

Aperture Education, the leading provider of research-based social and emotional learning (SEL) assessments for K-12 schools, and the Urban Assembly, an education nonprofit that advances the social and economic mobility of communities by improving public education, announced strong evidence of both positive student-to-student and student-to-teacher relationship building with Windsor (Connecticut) Public School’s thriving SEL program.

Over the last couple of years, Windsor has made remarkable strides in its implementation of SEL, as demonstrated by the compelling data trends. With keen attention to the SEL needs of its students, Windsor has shown an impressive uptick in the proportion of students exhibiting typical to strong SEL abilities. In just one academic year, Windsor witnessed a significant increase, with 84% of students now demonstrating positive SEL skills, up from the previous year’s 79%. Notably, 28% of students exhibit strength in SEL competencies, up from the initial 16%, a testimony to the effectiveness of the SEL interventions.

“I am immensely proud of the work being done by our teachers, SEL Specialists and support staff who are committed to nurturing the social-emotional well-being of our students,” said Dr. Terrell Hill, Windsor Public Schools Superintendent. “Their dedication and commitment have played a pivotal role in achieving this growth in our students’ social-emotional learning competencies. Their passion for nurturing the holistic development of our students and their unwavering commitment to ensuring the success and well-being of our students is truly inspiring.”

The Connecticut State Department of Education (CSDE) announced a partnership with Aperture Education to provide a statewide SEL assessment for K-12 schools by providing the Devereux Student Strengths Assessment (DESSA) System and the DESSA-mini, an eight-question, one-minute version of the screening, available to all Connecticut districts at no cost.

Among the first districts to participate in this statewide initiative was Windsor Public Schools, which serves more than 3,300 students in six schools. Windsor uses the DESSA suite of assessments to measure students’ social and emotional skills, which provides information about eight key social and emotional competencies aligned to the CASEL framework, which helps cultivate skills and environments that advance students’ learning and development.

DESSA scores can be used to pinpoint each child’s specific strengths and opportunities for social and emotional growth, and guide strategies to promote these competencies across the school, in classes and small groups and with individuals. This data helps educators collaborate to identify students’ areas of growth and provide additional instruction to students in need.

“The key to our success is building a data-driven culture,” said Dr. Michael Mallery, District Coordinator of Social Emotional Learning for Windsor Public Schools. “We are able to provide impactful SEL intervention with our team of dedicated SEL specialists because we have clear insights from the DESSA assessments. Now we can empower our teachers and our families by identifying which students need support and providing it as an integrated part of their school day.”

An important part of Windsor Public School’s success is their partnership with the Urban Assembly, which supports the district with SEL implementation, integration, evaluation and capacity building. Urban Assembly also provides professional learning that supports staff to build their own social and emotional skill development, as well as engaging with families and the community.

“The concept of SEL was introduced 60 years ago, but the pandemic really highlighted issues of anxiety, stress and mental health,” said Jessica Adamson, Chief Strategy Officer, Aperture. “Schools saw the importance of SEL programs not only to address the wellbeing concerns stemming from the pandemic, but also as a way to combat bullying and school violence, and prepare students for success once they graduate. Connecticut is demonstrating great leadership by providing access to a data-driven program that can be tailored to the needs of the students, educators and community. Even in the early stages, the school system is seeing impressive results that will only get better with a continued focus on using data to tailor supports to students’ strengths and needs.”

About Aperture Education

Aperture Education has empowered nearly 8,500 schools and out-of-school time programs across North America to measure, strengthen, and support social and emotional competence in K-12 youth and educators. The Aperture System includes the DESSA suite of strength-based assessments, CASEL™-aligned intervention strategies, and robust reporting, all in one easy-to-use digital platform. This system enables education leaders to make strategic, data-based decisions about SEL within their organizations. Aperture has supported more than one million students in their social and emotional growth and continues to develop innovative solutions to bring the whole child into focus. To learn more, visit http://www.ApertureEd.com.

About Urban Assembly

The Urban Assembly is an education nonprofit that advances the social and economic mobility of communities through the design of our high-impact, public schools and by offering learning solutions to school districts across the country. The UA provides school support in 4 key areas to advance student growth: Algebra, Social-Emotional Learning, Postsecondary Readiness, and Alumni Success. The UA engages hundreds of public, private, and non-profit sector partners to increase educational opportunities and close the opportunity gap. To learn more, visit http://www.urbanassembly.org.

Share article on social media or email:

Selecting Digital Health Technologies in Decentralized Clinical Trials, Upcoming Webinar Hosted by Xtalks


Factors in this validation include evaluating the clinical investigation population, design and operation of the intended digital health technology and ability to allow the use of a study participant’s own digital health technology.

As decentralized clinical trials are becoming mainstream, there is a need for a standard regulated framework to structure digital health technologies (DHTs) for clinical investigations. Healthcare and regulatory authorities are endeavoring to provide a digital standard for conventional use by both academic and industry clinical research centers by issuing new directive guidelines.

This webinar is intended to provide the best digital health tool practices as expected by the current thinking of the US Food and Drug Administration (FDA). To achieve adequate validation of digital health technologies, stakeholders should ensure that the technologies utilized are sufficient to support their use, function and interpretability. Factors in this validation include evaluating the clinical investigation population, design and operation of the intended digital health technology and ability to allow the use of a study participant’s own digital health technology.

The featured speaker will highlight how digital health technology items should be presented in a submission. Useful directives for validation and practicality will be outlined as well as how to evaluate clinical endpoints in the context of digital health technologies and how to proceed if a novel clinical endpoint arises when leveraging these technologies.

Digital practices should adequately measure privacy-related risks. Therefore, a primer featuring key items to examine within an Informed Consent document, that leverages digital health technologies, will also be examined. Aspects of record protection and retention, as well as sponsor’s and primary investigator’s roles and responsibilities will also be reviewed.

Register for this webinar to ensure the appropriate evaluation, inclusion and presentation of all key digital health technologies in decentralized clinical trials when submitting the next Investigational Drug Application to the FDA.

Join Jorge M. Rivas, MD, PhD, Director of Regulatory Affairs, US, Amador Bioscience, for the live webinar on Wednesday, May 10, 2023, at 12pm EDT (9am PDT).

For more information, or to register for this event, visit Selecting Digital Health Technologies in Decentralized Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Dr. Roberto Velasco of Uptown Cosmetic & Implant Dentistry Named a One Of the Top Prosthodontist by Houstonia Magazine


Dr. Roberto Velasco named top prosthodontist by Houstonia Magazine

Dr. Roberto Velasco named top prosthodontist by Houstonia Magazine

Houstonia Magazine recently named Dr. Roberto Velasco as one of the top prosthodontists in Houston. Dr. Velasco, renowned for his expertise in dental implants and smile makeovers, has established a distinguished reputation for offering outstanding care to patients requiring tooth replacement, and damaged teeth restoration.

About Dr. Roberto Velasco

Dr. Roberto Velasco is a native of Colombia and graduated in the top five of his class at Xavier University in 1990. After practicing general dentistry for seven years, he became increasingly interested in dental implants and esthetics, which led him to pursue post-graduate training at New York University in 1992.

In 1997, Dr. Velasco attended Nova Southeastern University’s Prosthodontic program. Upon completing his residency, Dr. Velasco was appointed as a full-time faculty member at the dental school, teaching both undergraduate and postgraduate programs. He also served as the course director in Implant Dentistry, Dental Bio-Materials, and Occlusion.

After being trained in Europe on the All-on-4 Teeth-in-a-Day implant procedure, Dr. Velasco relocated to Houston in 2010. Since then, he has successfully completed more than 3,500 All-on-4 Teeth-in-a-Day implant procedures and restored a vast number of implants. Through the use of innovative techniques, he ensures the highest success rate, as well as the most aesthetically pleasing and functional restorations for his patients. His dedication to embracing new technological advances aims to continually enhance the well-being of his patients.

Named a Top Prosthodontist by Houstonia Magazine

Being named a Top Prosthodontist by Houstonia Magazine is a prestigious recognition that underscores Dr. Velasco’s dedication to excellence in his field. Houstonia Magazine is a respected local publication that has a discerning process of selecting top professionals in various industries, including healthcare and dentistry.

This acknowledgment serves as a testament to Dr. Velasco’s commitment to providing the highest quality care for his patients. It also signifies that his expertise and experience have been thoroughly vetted, making him a trusted resource for those seeking dental treatments in Houston.

Earning this distinction helps to build trust and credibility with potential patients, as it highlights Dr. Velasco’s dedication to staying abreast of the latest advancements in dentistry and maintaining the highest standards of care.

Dental Implants by Dr. Velasco

At Uptown Cosmetic & Implant Dentistry, Dr. Velasco offers state-of-the-art dental implant services in Houston, TX. Dental implants have revolutionized dentistry in the last 25 years, providing a more permanent solution to replace missing teeth than traditional dentures or bridges. They are designed to look and feel just like natural teeth, improving patients’ confidence and overall oral health.

Dr. Velasco’s extensive training and experience in prosthodontics make him an expert in the field of implant dentistry. His dental implant procedures have changed thousands of lives, and he consistently stays up-to-date with the latest discoveries in the industry.

Dental Implant Surgery and Procedures

A dental implant replaces a tooth’s root or roots, utilizing lightweight, strong, and biocompatible titanium materials. Dental implants have proven to be highly successful when placed securely by specially trained dentists like Dr.Velasco.

Dental implant procedures at Uptown Cosmetic & Implant Dentistry include:

  • Teeth in an HOUR
  • Cosmetic Single Tooth Replacement
  • Fixed Implant Dentures
  • Removable Implant Dentures
  • All-On-Four Dental Implants
  • Full Mouth Reconstruction

How to Schedule a Consultation

If you are in need of a prosthodontist in Houston, Texas, Dr. Roberto Velasco is the right choice. With his extensive training and experience in dentistry and commitment to providing top-quality care, you can trust Dr. Velasco and his team to help you achieve a beautiful smile and optimal oral health.

Call Uptown Cosmetic & Implant Dentistry at 713-960-9623 to schedule your free consultation today.

Share article on social media or email:

ASEA launches world’s first redox clay mask, ASEA® Redox Clay Mask


ASEA proudly announces the world’s first redox signaling clay mask after years of development, ASEA® Redox Clay Mask.

ASEA® Redox Clay Mask is the first ever clay mask on the market that contains active redox signaling molecules. These tiny molecules are the communication centers in each of your cells. Redox signaling molecules contribute to your surface skin cell health by supporting the communication to replace, renew, or create new cells.

ASEA has now incorporated this technology—together with the power of bentonite clay—in our Redox Clay Mask. The negative charge in bentonite clay are highly absorbent. Not only does the clay act like a magnet to draw out positively-charged impurities from the skin, but the clay also prepares the pores in the skin to absorb the redox-signaling molecules in the mask.

After 15 days of using the ASEA® Redox Clay Mask, an overwhelming majority of study participants (97%) found our product to be user-friendly, and a significant number of them noticed an improvement in their skin’s overall appearance (73%). The majority also saw a remarkable improvement in their skin’s smoothness (88%) and a reduction in oily skin (55%). In just 15 days, 39% noticed an improvement in the appearance of fine lines and wrinkles, and 30% noticed a reduction in the redness of the skin.

After 30 days, 100% of participants found our product to be user-friendly. What’s more, a significant majority noticed a remarkable improvement in their skin’s overall appearance (80%), smoothness (87%), fine lines (67%), wrinkles (50%), and oily skin (53%). Moreover, almost half of the participants saw a reduction in redness (47%) and a boost in hydration (60%).

ASEA® Redox Clay Mask is produced in our facility that is FDA-registered and NSF- certified and backed by an independent lab to contain active redox signaling molecules. The company conducts ongoing research to ensure its products are safe and meet the highest production standards. Details on ASEA safety studies and product certifications can be found on http://www.aseaglobal.com

On April 24, 2023, ASEA will launch the ASEA® Redox Clay Mask in the US market. Join us for the launch call of the world’s first redox-signaling clay mask.

Zoom Link: https://ASEA.zoom.us/j/5151051785

Monday, April 24 @ 12 pm (noon) MT

ASEA, a global leader in redox technology, is pioneering cellular health products through a principles-based, direct-selling business model. ASEA offers first-to-market revolutionary redox signaling molecule products, helping your cells work together as they’re meant to do. Our redox technology supports the body’s natural cellular renewal and communication and signals the regulation of genetic pathways. ASEA redox products power the potential of your cells, body, and life to help you feel your best.* Founded in 2010, ASEA currently operates in 33 international markets. For more information about ASEA® products or the accompanying business opportunity, visit ASEA Cellular Health.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This material is intended for a US audience only.

# # #

Share article on social media or email: